Patel Sanjiv: insider trades.
Patel Sanjiv reported 4 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($2.8M), across 1 company.
- Transactions
- 4
- Purchases (P)
- 0
- Sales (S)
- 3
- Companies
- 1
- Name as filed
- Patel Sanjiv
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Relay Therapeutics, Inc. (RLAY) | Director, Officer · President and CEO | 4 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-08 | Relay Therapeutics, Inc. | S | 48,199 | $18.94 | 519,500 | Form 4 |
| 2026-08-17 | Relay Therapeutics, Inc. | S | 48,199 | $20.33 | 567,699 | Form 4 |
| 2026-07-07 | Relay Therapeutics, Inc. | S | 48,199 | $19.58 | 615,898 | Form 4 |
| 2026-06-30 | Relay Therapeutics, Inc. | A | 3,056 | $6.95 | 664,097 | Form 4 |
Questions
What stock did Patel Sanjiv buy or sell?
Patel Sanjiv reported 4 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($2.8M), across 1 company.
Is Patel Sanjiv the same person as other filers with this name?
This page covers SEC CIK 1816210 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/patel-sanjiv-1816210.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.